Note: Ingredients listed on restricted chemical lists
General Information
Version
15
Revision date
2025-12-20
Product name
L-1980/A-620-A2
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Aerospace PRC-DeSoto
Icons in SDS
Company Information
company name
PPG Aerospace PRC-DeSoto
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H351
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
25% (oral), 25% (dermal), 25% (inhalation)
Signal word
Warning
Hazard statements
Flammable liquid and vapor. Suspected of causing cancer.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Response
IF exposed or concerned Get medical advice or attention. IF ON SKIN (or hair) Take off immediately all contaminated clothing. Rinse skin with water.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. Avoid contact with skin and clothing. Wash thoroughly after handling. Emits toxic fumes when heated.
2.3 Other hazards
May form explosive peroxides. Hazardous reactions or instability may occur under certain conditions of storage or use. Prolonged or repeated contact may dry skin and cause irritation.
2.1 Classification of the substance or mixture
CARCINOGENICITY - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 25% (oral), 25% (dermal), 25% (inhalation)